Results of the fi rst human papilloma virus center in Hungary (2007-2011);Az elso magyarországi humán papillomavírus központ tapasztalatai (2007-2011)

Orvosi Hetilap

Volumn 152, Issue 45, 2011, Pages 1804-1807

  Galamb, Ádám ^a   Pajor, Attila ^a   Langmár, Zoltán ^a   Sobel, Gábor ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

cervical carcinoma; human papillomavirus infection; preblastomatosis; screening

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUNGARY; INFECTION RATE; MAJOR CLINICAL STUDY; MASS SCREENING; MIXED INFECTION; NONHUMAN; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; CERVIX UTERI; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; HUNGARY; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; TUMOR VIRUS INFECTIONS; YOUNG ADULT;

EID: 80054858867     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2011.29233     Document Type: Article

References (15)

1. Walboomers, J. M., Jacobs, M. V., Manos, N. M. és mtsai: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol., 1999, 189, 12-19 (Pubitemid 29406813)
2. International Agency for Research on Cancer. Available at: http://www.iarc.fr/ENG/Press-Releases/Evaluation.pdf. Accessed November 29, 2005.
3. Parkin, D. M., Bray, F., Ferlay, J. és mtsai: Global cancer statistics, 2002. CA Cancer J. Clin., 2005, 55, 74-108. (Pubitemid 40372904)
4. De Sanjosé, S., Diaz, M., Castellsague, X. és mtsai: Worldwide prevalence and genotype distribution of cervical human papillo-mavirus DNA in woman with normal cytology: a meta-analysis. Lancet Infect. Dis., 2007, 7, 453-459. (Pubitemid 46962343)
5. Peyton, C. L., Gravitt, P. E., Hunt, W. C. és mtsai: Determinants of genital human papillomavirus detection in a US population. J. Infect. Dis., 2001, 183, 1554-1564. (Pubitemid 32466692)
6. Ferreccio, C., Corvalán, A., Margozzini, P. és mtsai: Baseline assessment of prevalence and geographical distribution of HPV types in Chile using self-collected vaginal samples. BMC Public Health, 2008, 8, 78.
7. Ronco, G., Ghisetti, V., Segnan, N. és mtsai: Prevalence of human papillomavirus infection in women in Turin, Italy. Eur. J. Cancer, 2005, 41, 297-305. (Pubitemid 40126963)
8. Banura, C., Franceschi, S., Doorn, L. J. és mtsai: Infection with human papillomavirus and HIV among young woman in Kampala, Uganda. J. Infect. Dis., 2008, 197, 555-562. (Pubitemid 351321533)
9. Markowitz, L. E., Sternberg, M., Dunne, E. F. és mtsai: Seropreva-lence of human papillomavirus types 6, 11, 16 and 18 in the United States. National Health and Nutrition Examination Survey 2003-2004. J. Infect. Dis., 2009, 200, 1059-1067.
10. Dunne, E. F., Unger, E. R., Sternberg, M. és mtsa: Prevalence of HPV infection among females in the United States. JAMA, 2007, 297, 813-819. (Pubitemid 46333946)
11. Wright, T. C. Jr., Schiffman, M.: Adding a test for human papil-lomavirus DNA to cervical-cancer screening. N. Eng. J. Med., 2003, 348, 489-490. (Pubitemid 36159883)
12. Bosch, F. X.: Epidemiology and natural history of human papil-lomavirus infections and type-specifi c implications in cervical neoplasia. Vaccine, 2008, 26 (Suppl. 10), K1-K16.
13. Muñoz, N., Castellsagué, X., de González, A. és mtsai: HPV in the etiology of human cancer. Vaccine, 2006, 24 (Suppl. 3), S1-S10. (Pubitemid 44293019)
14. Cuzick, J., Clavel, C.: Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int. J. Cancer, 2006, 119, 1095-1101. (Pubitemid 44116919)
15. Kjaer, S., Hogdall, E.: The absolute risk of cervical abnormalities in high risk human papillomavirus-positive, cytologically normal woman over a 10-year period. Cancer Res., 2006, 66, 106-130.